Medical education · Dr. Ulrich Hayashi

11 Sept 2026 · Virtual · Dr. Ulrich Hayashi, Christie NHS Foundation Trust · MSL Dr. Anna Becker · Nephrada

ReviewedVeeva CRMENG-0148—

Capture insight from this engagement

Location: Christie NHS Foundation Trust
Therapeutic area: Nephrology
Country: United Kingdom
Stakeholder tier: Tier 2
Strategic objective: Not linked
Initiative: Not linked
MSL: ABDr. Anna BeckerMSL, Nephrology (DACH)
Product: Nephrada (nephradin)

Topics discussed

Patient-reported outcomes
APRIL pathway mechanism
Treatment burden and fatigue

Scientific content used

Surrogate-endpoint evidence review

Questions raised

No questions recorded.

Notes

Medical education with renal pathologist at Christie NHS Foundation Trust. Discussed patient-reported outcomes, april pathway mechanism, treatment burden and fatigue.

Insights captured (0)

Capture insight

No insights captured from this engagement.

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

No follow-ups recorded.

Quality ratings

1–5, rated at review

Scientific relevance: 3
Strategic relevance: 2
Depth of exchange: 3
Actionability: 5

Data lineage

Source system: Veeva CRM
Sync: Veeva CRM · synced 2026-09-15 08:00 UTC
System of record: Veeva CRM
Record id: ENG-0148

Audit history (0)

All create, update and approval events for this record

No audit events in sample data